α-Helical stapling of IAPP peptide derivatives prevents their aggregation into toxic amyloid fibrils, a strategy relevant to diabetes and peptide drug development.
Aggregation preventionHelical stapling of IAPP prevents toxic amyloid fibril formation in diabetes-relevant peptides
What the researchers found
α-Helical stapling effectively prevents IAPP peptide aggregation and amyloid-associated cytotoxicity, with efficacy varying by stapling strategy.
Why it matters
Amyloid deposits contribute to beta cell death in diabetes. Strategies preventing IAPP aggregation could lead to disease-modifying therapies and more stable peptide drugs.
How the study worked
Systematic study of multiple stapling (side chain-to-side chain macrocyclization) strategies on IAPP derivatives; aggregation, toxicity, and structural analysis.
What this study cannot tell us
In vitro study — stapled peptide behavior in vivo (in the pancreas) may differ; manufacturing complexity of stapled peptides.
How to read the evidence
Chemical biology study — demonstrates a technological approach with therapeutic potential but no in vivo data.
When this study was published
Published 2026 in ACS Chemical Biology.
The bigger picture
Peptide stapling technology has broad applications — from preventing disease-causing protein aggregation to creating more stable peptide drugs for various conditions.
Questions still open
- Could stapled IAPP derivatives be developed as diabetes therapeutics?
- Does stapling maintain IAPP's beneficial biological functions while preventing aggregation?
Common questions
What is peptide stapling?
How does protein clumping relate to diabetes?
Read the original research
Probing the Effect of α-Helical Stapling Strategies on the Inhibition of Peptide Aggregation and Amyloid Cytotoxicity.
ACS chemical biology, 21(1), 96-106
Citation
Babych, Margaryta; Nguyen, Phuong Trang; Bérubé, Frédérique; Bourgault, Steve. (2026). Probing the Effect of α-Helical Stapling Strategies on the Inhibition of Peptide Aggregation and Amyloid Cytotoxicity.. ACS chemical biology, 21(1), 96-106. https://doi.org/10.1021/acschembio.5c00685